Literature DB >> 6799605

Gonadotrophin, testosterone and prolactin interrelationships in cadmium-treated rats.

E A Zylber-Haran, H Gershman, E Rosenmann, I M Spitz.   

Abstract

We have investigated the long-term effect of a single subcutaneous injection of cadmium chloride on plasma testosterone and gonadotrophin levels and the prolactin response to the dopaminergic antagonist metoclopramide in the rat. Twelve days after treatment with cadmium there was testicular necrosis, associated with a decrease in testosterone concentration and atrophy of the accessory sexual glands. By 185 days, partial recovery of the accessory sexual glands indicated by Leydig cell regeneration and a slight rise in testosterone levels had occurred. There was, however, persistent damage to the germinal epithelium. Concentrations of LH increased eightfold above controls by day 12, remained raised until 60 days and then decreased to threefold above controls at 280 days. In contrast, FSH levels reached a maximum between 60 and 130 days and remained persistently raised. The peak prolactin response to metoclopramide in cadmium-treated rats was depressed 12 days after cadmium administration and levels remained low at 19 and 75 days. Normal prolactin responses to metoclopramide were obtained 130 days after cadmium treatment using 1:0 mg metoclopramide/kg or 280 days after treatment using 0.25 mg/kg. When control and cadmium-treated rats were castrated at 280 days and then given metoclopramide 10 days later, the prolactin response was significantly reduced. It is concluded that the impaired prolactin response to metoclopramide in cadmium-treated rats is reversible. Prolactin returns to normal in parallel with regeneration of the Leydig cells, partial restoration of the accessory sex organ weight, slight increase in plasma testosterone and decrease in LH levels. These results suggest that testosterone is not solely responsible for the maintenance of normal prolactin secretion in the male rat.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6799605     DOI: 10.1677/joe.0.0920123

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Cadmium effects on dopamine turnover and plasma levels of prolactin, GH and ACTH.

Authors:  A Lafuente; N Márquez; D Pazo; A I Esquifino
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

2.  Effects of low-dose cadmium exposure during gestation and lactation on development and reproduction in rats.

Authors:  Xue Luo; Lianbing Li; Mingfu Ma; Renyan Li
Journal:  Environ Sci Pollut Res Int       Date:  2015-03-05       Impact factor: 4.223

3.  Tissue susceptibility factors in cadmium carcinogenesis. Correlation between cadmium-induction of prostatic tumors in rats and an apparent deficiency of metallothionein.

Authors:  M P Waalkes; A Perantoni; S Rehm
Journal:  Biol Trace Elem Res       Date:  1989 Jul-Sep       Impact factor: 3.738

4.  Cadmium induces changes on ACTH and PRL cells in Podarcis sicula lizard pituitary gland.

Authors:  I Ferrandino; R Favorito; M C Grimaldi
Journal:  Eur J Histochem       Date:  2010-11-05       Impact factor: 3.188

5.  The association of urinary cadmium with sex steroid hormone concentrations in a general population sample of US adult men.

Authors:  Andy Menke; Eliseo Guallar; Meredith S Shiels; Sabine Rohrmann; Shehzad Basaria; Nader Rifai; William G Nelson; Elizabeth A Platz
Journal:  BMC Public Health       Date:  2008-02-23       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.